| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 11/25/2014 | US8895256 Immunomodulation using placental stem cells |
| 11/25/2014 | US8895236 Composition for cryopreservation comprising nicotinamide, glycerol and red blood cells |
| 11/25/2014 | US8895081 Formulation for treatment of dry mouth and mouth sores |
| 11/25/2014 | US8895074 Therapeutic application of parenteral krill oil |
| 11/25/2014 | US8895028 Methods and compositions for dengue virus 3 (DV3) infectious clone |
| 11/25/2014 | US8894993 Mitochondria-targeted antioxidants |
| 11/25/2014 | US8894992 Compositions and soft tissue replacement methods |
| 11/25/2014 | US8894972 Method for treating or preventing a pancreatic dysfunction |
| 11/25/2014 | US8894599 Uterine stimulant sticks |
| 11/20/2014 | US20140342452 Islet Cells From Human Embryonic Stem Cells |
| 11/20/2014 | US20140342015 Amniotic Membrane Powder and Methods of Making |
| 11/20/2014 | US20140342014 Methods of sterilizing fetal support tissues |
| 11/20/2014 | US20140342012 Preparation and use of fish skin fermentation product |
| 11/20/2014 | US20140342011 Skin salve for treating intertrigo |
| 11/20/2014 | US20140342010 Use of foti to enhance stem cell mobilization and proliferation |
| 11/20/2014 | US20140342007 Methods of manufacturing bioactive gels from extracellular matrix material |
| 11/20/2014 | US20140341977 Treatment of amd using aav sflt-1 |
| 11/20/2014 | US20140341965 Compositions and Methods Comprising Biodegradable Scaffolds and Retinal Pigment Epithelial Cells |
| 11/20/2014 | US20140341948 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 11/20/2014 | US20140341921 Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
| 11/20/2014 | US20140341873 New Strain of Cadmium-Removing Lactobacillus plantarum Bacterium, and Uses of the Same |
| 11/20/2014 | US20140341871 Regenerative tissue matrix |
| 11/20/2014 | US20140341870 Biocomposite for regeneration of injured tissue and organs, a kit for making the biocomposite, a method of making the biocomposite and a method of treating injuries |
| 11/20/2014 | US20140341868 Treatment of limb ischemia |
| 11/20/2014 | US20140341867 Treatment of stroke using isolated placental cells |
| 11/20/2014 | US20140341866 Cell tissue gel containing collagen and hyaluronan |
| 11/20/2014 | US20140341864 Methods for producing retinal tissue and retina-related cell |
| 11/20/2014 | US20140341863 Adult mesenchymal stem cell (msc) compositions and methods for preparing the same |
| 11/20/2014 | US20140341862 Method for producing a biological tissue construct and use of specifically obtained autologous cells |
| 11/20/2014 | US20140341861 Rapid infusion of autologous bone marrow derived stem cells |
| 11/20/2014 | US20140341860 Methods for treating cartilage disorders, diseases, and injuries |
| 11/20/2014 | US20140341859 Method for treatment of damaged site of bone |
| 11/20/2014 | US20140341858 Neuron generation, regeneration and protection |
| 11/20/2014 | US20140341857 Combination of oncolytic adenoviruses with histone deacetylase inhibitors |
| 11/20/2014 | US20140341856 Method of controlling tomato plant viruses |
| 11/20/2014 | US20140341855 Reuterin-Producing Lactobacillus Brevis |
| 11/20/2014 | US20140341853 Bacteria-Mediated Therapy for Cancer |
| 11/20/2014 | US20140341809 High-Affinity DMF5 T Cell Receptor (TCR) Variants |
| 11/18/2014 | US8889831 Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate |
| 11/18/2014 | US8889681 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies |
| 11/18/2014 | US8889630 Method for hair regrowth using Granulocyte-Colony Stimulating Factor |
| 11/18/2014 | US8889625 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 11/18/2014 | US8889419 Methods for enhanced virus-mediated DNA transfer using molecules with virus- and cell-binding domains |
| 11/18/2014 | US8889415 Method for expansion of human corneal endothelial cells |
| 11/18/2014 | US8889411 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 11/18/2014 | US8889375 Hypoglycemic effect enhancer |
| 11/18/2014 | US8889179 Membrane |
| 11/18/2014 | US8889168 Stem cell capture and immobilization coatings for medical devices and implants |
| 11/18/2014 | US8889124 Tolerogenic populations of dendritic cells |
| 11/18/2014 | US8889122 Cellular cardiomyoplasty as supportive therapy in patients with heart disease |
| 11/18/2014 | US8889119 Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy |
| 11/18/2014 | US8889118 Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
| 11/18/2014 | US8889105 Bacteriophage compositions for treatment of bacterial infections |
| 11/13/2014 | US20140336780 Extracellular Matrix (ECM) Structures for Tissue Regeneration |
| 11/13/2014 | US20140336443 Method of repairing age and disease immune dysfunction and cellular senescence with lymphoid stem cells and then re-applying those for therapeutic use |
| 11/13/2014 | US20140336122 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 11/13/2014 | US20140335607 Methods and compositions relating to restricted expression lentiviral vectors and their applications |
| 11/13/2014 | US20140335195 Platelet lysate gel |
| 11/13/2014 | US20140335187 Compositions and methods for decreasing the effects of alcohol |
| 11/13/2014 | US20140335185 Novel microcarrier beads |
| 11/13/2014 | US20140335183 Wound healing profile |
| 11/13/2014 | US20140335149 Wound-healing promoting material |
| 11/13/2014 | US20140335145 Biomaterials and implants for enhanced cartilage formation, and methods for making and using them |
| 11/13/2014 | US20140335144 Tissue scaffolds derived from forestomach extracellular matrix |
| 11/13/2014 | US20140335131 Probiotic prevention and treatment of colon cancer |
| 11/13/2014 | US20140335073 Nutrition for prevention of infections |
| 11/13/2014 | US20140335066 Lactobacillus plantarum inducia dsm 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against clostridium difficile |
| 11/13/2014 | US20140335065 Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| 11/13/2014 | US20140335064 Human skin equivalents expressing exogenous polypeptides |
| 11/13/2014 | US20140335063 Delivery methods and compositions for nuclease-mediated genome engineering |
| 11/13/2014 | US20140335062 Co-cultured mesenchymal stem cells and myocytes |
| 11/13/2014 | US20140335061 Supplemented oil compositions and methods for improved health |
| 11/13/2014 | US20140335059 Stem cell-derived neural cells for cell therapy in neurological disorders |
| 11/13/2014 | US20140335056 Sustained releasing pharmaceutical composition |
| 11/13/2014 | US20140335055 Regenerative autologous cell therapies and methods of use |
| 11/13/2014 | US20140335053 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 11/13/2014 | US20140335050 Methods, compositions, and kits for the treatment of cancer |
| 11/11/2014 | US8884096 Method for the production of antibodies |
| 11/11/2014 | US8883733 Cell cultivation in chitosan alginate hydrogel beads |
| 11/11/2014 | US8883716 Method for treating damaged tissue of the CNS |
| 11/11/2014 | US8883502 Expandable cell source of neuronal stem cell populations and methods for obtaining and using them |
| 11/11/2014 | US8883500 Method of preparing adenosine-resistant anti-tumor T lymphocytes for adoptive immunotherapy |
| 11/11/2014 | US8883499 Systems and methods for isolating and using clinically safe adipose derived regenerative cells |
| 11/11/2014 | US8883498 Method for inducing differentiation of pluripotent stem cells into skeletal muscle or skeletal muscle progenitor cells |
| 11/11/2014 | US8883495 Human T-cell population |
| 11/11/2014 | US8883409 Method of reducing pathogens in whole blood by illuminating with ultraviolet light under low oxygen conditions |
| 11/11/2014 | US8883227 Plant pathogen inhibitor combinations and methods of use |
| 11/11/2014 | US8883219 Nutritional compositions with coated lipid globules |
| 11/11/2014 | US8883210 Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| 11/11/2014 | US8883189 Intraocular encapsulation of oxygenic bacteria |
| 11/11/2014 | US8883184 Methods and compositions for regenerating connective tissue |
| 11/11/2014 | US8883182 Method and material for enhanced tissue-biomaterial integration |
| 11/11/2014 | US8883138 Adiponectin production accelerating composition |
| 11/11/2014 | US8883136 Methods for accelerating the healing of connective tissues injuries and disorders |
| 11/11/2014 | US8882850 Multi-formed collagenous biomaterial medical device |
| 11/06/2014 | US20140329316 Tissue repair with multipotent cells |
| 11/06/2014 | US20140329310 Activated T Cells |
| 11/06/2014 | US20140329286 Equol concentration increasing agent containing psicose as active ingredient |
| 11/06/2014 | US20140328940 Modulation of axon degeneration |
| 11/06/2014 | US20140328939 Method for preparing biocompatible small intestinal mucosa hydrogel capable of controlling in-vivo degradation period |